Breast Cancer Flashcards

1
Q

What cells do breast cancer arise from?

A

epithelial cells of the milk ducts and lobules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What (approx) percentage of ppl with Breast cancer have a familial genetic mutation?

A

~ 5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which of the BRCA mutations is associated with prostate cancer (in men)

A

BRCA 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does the BRCA1 protein do?

A

It’s a tumour suppressor

DNA repair (double stranded break repair)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are PARP inhibitors?

A

poly-ADP-ribose polymerase (PARP) inhibitors

causes double-stranded DNA breaks to occur
- normally this would be repaired by BRCA, but when it’s deficient the cell just dies instead (for example breast cancer cells where there is a second BRCA mutation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What age are women in Australia screened for breast cancer?

A

50-74: invited for beast mammogram 2 yearly in Australia

40-49 and > 74 : not invited, but have access to free screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Definition of breast cancer in-situ?

A

hasn’t breached the basement membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical factors associated with BRCA mutations?

A

• Invasive breast cancer ≤ 30 years

• Triple-negative breast cancer < 60 years

• Male invasive breast cancer of any age

• Ovarian or primary peritoneal cancer

• Ashkenazi Jewish heritage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cancer prevention interventions if BRCA positive?

A

• Risk-reducing bilateral mastectomy (offer at least)

• Risk-reducing salpingo-oophorectomy once childbearing is complete (before 40 years of age if possible)

• Increased surveillance – consider from 30 years of age including breast MRI

• Chemoprevention with tamoxifen, anastrazole or exemestane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Investigations for breast cancer

A

Imaging
- including size, invasion, axillary lymph node status, look for mets

Histology
- grade
- Ki-67 (marker of proliferation)
- ER/ PR/ HER2 receptor status
- molecular profiling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which stage Breast Cancers are potentially curable?

A

I to III

exceptions:
- HER2-positive stage IV (achieve long term control at least)
- sometimes oligometastatic disease pretty well controlled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Three broad categories of Breast Cancer (receptor based)

A
  1. Hormone receptor-positive
  2. HER 2 positive
  3. Triple-negative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What kind of breast cancers tend to have recurrences even at a late stage?

A

Hormone positive breast cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Most common kind of breast cancer (out of hormone receptor positive, HER 2 positive and triple-neg)

A

Hormone receptor-positive (65%)

HER 2 positive (20%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Main deciding factor in suitability of chemo in Breast Cancer?

A

lymph node-positive

(or if stage IV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Choose of ostroegen receptor medication, based on menopausal status

A

Pre-menopause: tamoxifen

Post-menopause: aromatase inhibitor (or if they have ovarian function suppressed)

17
Q

Adverse effects of endocrine therapies in breast cancer?

A

Common toxicities:
- hot flushes,
- arthralgia/ myalgia
- vaginal atrophy

Tamoxifen specific:
- VTEs
- endometrial cancers

Aromatase inhibitors
- accelerated bone loss

18
Q

Management of early stage breast cancer?

A

Wide Local Exicision + Local Radiotherapy

+/- chemo (neoadjuvant)
+/- hormone therapy
+/- anti-oestrogen agents

19
Q

HER 2 inhibitors?

A

trastuzumab (herceptin)
pertuzumab

20
Q

Anti-oestrogen agents (in breast cancer) by class

A

oestrogen receptor antagonists: tamoxifen, raloxifene, fulvestrant (causes receptor to degrade also)

aromatase inhibitors: letrozole, anastrazole

21
Q

Treatment of widespread breast cancer

A

generally chemo - probably delay death
+/- endocrine therapy
+/- HER2 therapy